BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
259 results:

  • 1. Computer Vision and Machine-Learning Techniques for Automatic 3D Virtual Images Overlapping During Augmented Reality Guided Robotic Partial Nephrectomy.
    Amparore D; Sica M; Verri P; Piramide F; Checcucci E; De Cillis S; Piana A; Campobasso D; Burgio M; Cisero E; Busacca G; Di Dio M; Piazzolla P; Fiori C; Porpiglia F
    Technol Cancer Res Treat; 2024; 23():15330338241229368. PubMed ID: 38374643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.
    d'Izarny-Gargas T; Isnard P; Boudhabhay I; Buob D; Moktefi A; Linster C; Hummel A; Esteve E; Audard V; Lazareth H; Maroun N; Hertig A; Gosset C; Jouzel C; Permal S; Domenger C; Kosmider O; Rabant M; Karras A; Duong Van Huyen JP
    Kidney Int; 2023 Dec; 104(6):1206-1218. PubMed ID: 37769965
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.
    Falagario UG; Abbadi A; Remmers S; Björnebo L; Bogdanovic D; Martini A; Valdman A; Carrieri G; Menon M; Akre O; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
    JAMA Netw Open; 2023 Sep; 6(9):e2332900. PubMed ID: 37695584
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Optimization of cardiovascular risk factor management in patients with bcr::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives.
    Krecak I; Verstovsek S; Lucijanic M
    Ann Hematol; 2024 May; 103(5):1513-1523. PubMed ID: 37665349
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Acute kidney injury in children with haematological malignancy: a territory-wide study.
    Lam SY; Chan EY; Cheng FWT; Ma ALT; Ha SY
    Pediatr Nephrol; 2023 Nov; 38(11):3823-3833. PubMed ID: 37219640
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dysregulation of non-coding RNAs in Wilms tumor.
    Taheri M; Hussen BM; Abdullah SR; Ghafouri-Fard S; Jamali E; Shojaei S
    Pathol Res Pract; 2023 Jun; 246():154523. PubMed ID: 37201386
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
    Gama A; Xu H; Yang XJ; Choy B
    Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
    [No Abstract]    [Full Text] [Related]  

  • 9. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
    Shen Q; Liu YX; He Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.
    Zhai T; Dou M; Ma Y; Wang H; Liu F; Zhang L; Chong T; Wang Z; Xue L
    Lipids Health Dis; 2023 Mar; 22(1):39. PubMed ID: 36915125
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A rare case of Klippel-Trenaunay syndrome presenting with chronic myeloid leukemia.
    Coşkun Ç; Aksu T; Gümrük F; Ünal Ş
    Turk J Pediatr; 2023; 65(1):124-128. PubMed ID: 36866992
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. miR-613 suppresses renal cell carcinoma proliferation, invasion and migration by regulating the AXL/AKT pathway.
    Duan W; Pan S; Zhai Y; Deng Q; Ren W; Du C; Sun Y
    Exp Biol Med (Maywood); 2023 Feb; 248(4):281-292. PubMed ID: 36852468
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up.
    Larsen MK; Skov V; Kjaer L; Møller-Palacino NA; Pedersen RK; Andersen M; Ottesen JT; Cordua S; Poulsen HE; Dahl M; Knudsen TA; Eickhardt-Dalbøge CS; Koschmieder S; Pedersen KM; Çolak Y; Bojesen SE; Nordestgaard BG; Stiehl T; Hasselbalch HC; Ellervik C
    Eur J Haematol; 2022 Nov; 109(5):576-585. PubMed ID: 36054308
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis.
    Bai H; Jiang W; Wang D; Shou J; Li C; Xing N
    BMC Urol; 2022 Aug; 22(1):135. PubMed ID: 36038864
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma].
    Qin CP; Song YX; Ding MT; Wang F; Lin JX; Yang WB; DU YQ; Li Q; Liu SJ; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):663-668. PubMed ID: 35950389
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Towards zero percent treatment abandonment of patients with common and curable childhood cancer types in Blantyre, Malawi.
    Chakumatha E; Khofi H; Landman L; Weijers J; Bailey S; Chagaluka G; Molyneux E; Israels T
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29899. PubMed ID: 35869892
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Implementing the WHO Global Initiative for Childhood Cancer in Morocco: Survival study for the six indexed childhood cancers.
    Mechita NB; Cherkaoui S; Abousselham L; Benmiloud S; Kili A; Kababri ME; Maani K; Houdzi JE; Benajiba N; Madani A; Bennani M; Belakhel L; Bouffet E; Patte C; Harif M; Youbi M; Hessissen L
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29788. PubMed ID: 35796382
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The tricks for fighting against cancer using CAR NK cells: A review.
    Vahidian F; Khosroshahi LM; Akbarzadeh M; Jahanban-Esfahlan A; Baghbanzadeh A; Ali-Hassanzadeh M; Safarzadeh E
    Mol Cell Probes; 2022 Jun; 63():101817. PubMed ID: 35436564
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rules of Engagement: The Lymphocyte Receptor Ecosystem in Renal Cell Carcinoma.
    Krishna C; Hakimi AA
    Cancer Res; 2022 Mar; 82(5):764-765. PubMed ID: 35247895
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Incidence of bladder cancer in neuro-urological patients in France: a nationwide study.
    Michel F; Cancrini F; Bensadoun H; Cussenot O; Guillot-Tantay C; Rouprêt M; Karsenty G; Phé V
    World J Urol; 2022 Aug; 40(8):1921-1927. PubMed ID: 35182207
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.